MRK vs HCA
By Alex · Tickerpine
Merck & Company, Inc. vs HCA Healthcare, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | HCA |
|---|---|---|
| Price | $132.92 | $414.59 |
| Market cap | $327.94B | $89.76B |
| P/E ratio | 106.3 | 13.9 |
| ROE | 6.96% | — |
| Profit margin | 4.77% | 8.77% |
| Revenue growth | 5.10% | 8.70% |
| Dividend yield | 2.56% | 0.75% |
| Beta | 0.21 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs HCA in plain English
- MRK is the bigger company — about 3.7× the market cap of HCA.
- HCA is cheaper on earnings (P/E 13.9 vs 106.3).
- HCA is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.56% vs 0.75%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
HCA return calculator
See what $1,000 in HCA Healthcare, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.